BPC-157 Supports Vascular and Neurological Repair One underappreciated hallmark of long COVID is endothelial dysfunction damage to the lining of blood vessels that impairs circulation, oxygenation, and tissue delivery.7 BPC-157 has demonstrated angiogenic (new blood vessel formation) effects in research models, upregulating VEGFR2 and promoting collateral circulation in ischemic tissue.8 This matters for two reasons: Cardiovascular symptoms (breathlessness, reduced exercise tolerance, tachycardia) may partly reflect impaired tissue oxygenation from vascular damage Neurological symptoms (brain fog, cognitive impairment) may similarly reflect reduced cerebral blood flow BPC-157's neuroprotective effects shown across models of traumatic brain injury, dopamine dysregulation, and serotonin syndrome also suggest value in supporting the neurotransmitter disruption many long COVID patients experience.9 BPC-157 Modulates Inflammation Without Immune Suppression This is critical

These visible changes do not automatically indicate an issue with the bacteriostatic water
Methods Primers 138 SaricaC.Iorio-MorinC.Aguirre-PadillaD.NajjarA.PaffM.FomenkoA.et al (2021)
Peptide therapy and GLP-1 medications require individualized evaluation by a licensed healthcare provider
Lyophilized BPC-157 is stored at -20C for long-term storage and 2-8C for short-term use within 30 days
This illusion stems from the successful skin tightening results delivered by the Thermage procedure